These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2617655)

  • 21. High prevalence of multidrug-resistant strains of Vibrio cholerae, in a cholera outbreak in Tehran-Iran, during June-September 2008.
    Ranjbar M; Rahmani E; Nooriamiri A; Gholami H; Golmohamadi A; Barati H; Rajabifar D; Barati S; Sabet MS; Zamiri A; Haghighi S; Taifehashemi P; Nojomi M
    Trop Doct; 2010 Oct; 40(4):214-6. PubMed ID: 20709810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transition of drug susceptibilities of Vibrio cholerae O1 in Lao People's Democratic Republic.
    Phantouamath B; Sithivong N; Sisavath L; Munnalath K; Khampheng C; Insisiengmay S; Higa N; Kakinohana S; Iwanaga M
    Southeast Asian J Trop Med Public Health; 2001 Mar; 32(1):95-9. PubMed ID: 11485103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The status of antibiotic sensitivity of Vibrio cholerae 0:1 in Ecuador].
    Aldighieri S; Vela E; Pesantes C
    Med Trop (Mars); 1997; 57(1):98. PubMed ID: 9289622
    [No Abstract]   [Full Text] [Related]  

  • 24. Antimicrobial suceptibility of V. cholerae in north west, Ethiopia.
    Abera B; Bezabih B; Dessie A
    Ethiop Med J; 2010 Jan; 48(1):23-8. PubMed ID: 20607994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative effectiveness of co-trimoxazole and tetracycline in the treatment of Cholera.
    Grados P; Bravo N; Battilana C
    Bull Pan Am Health Organ; 1996 Mar; 30(1):36-42. PubMed ID: 8919724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vibrio cholerae O139 Bengal: a descriptive study.
    Hossain MS; Salam MA; Rabbani GH; Biswas R; Mahalanabis D
    J Health Popul Nutr; 2000 Jun; 18(1):27-32. PubMed ID: 11014767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Double-blind, randomized, controlled clinical trial of norfloxacin for cholera.
    Bhattacharya SK; Bhattacharya MK; Dutta P; Dutta D; De SP; Sikdar SN; Maitra A; Dutta A; Pal SC
    Antimicrob Agents Chemother; 1990 May; 34(5):939-40. PubMed ID: 2193628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tetracycline in the treatment of severe cholera due to Vibrio cholerae O139 Bengal.
    Hossain MS; Salam MA; Rabbani GH; Kabir I; Biswas R; Mahalanabis D
    J Health Popul Nutr; 2002 Mar; 20(1):18-25. PubMed ID: 12022154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new type of conjugative transposon encodes resistance to sulfamethoxazole, trimethoprim, and streptomycin in Vibrio cholerae O139.
    Waldor MK; Tschäpe H; Mekalanos JJ
    J Bacteriol; 1996 Jul; 178(14):4157-65. PubMed ID: 8763944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emergence of classical ctxB genotype 1 and tetracycline resistant strains of Vibrio cholerae O1 El Tor in Assam, India.
    Borkakoty B; Biswas D; Devi U; Yadav K; Mahanta J
    Trans R Soc Trop Med Hyg; 2012 Jun; 106(6):382-6. PubMed ID: 22521215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controlled comparison of tetracycline and furazolidone in cholera.
    Pierce NF; Banwell JG; Mitra RC; Caranasos GJ; Keimowitz RI; Thomas J; Mondal A
    Br Med J; 1968 Aug; 3(5613):277-80. PubMed ID: 4873660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypic and antibiogram pattern of V. cholerae isolates from a tertiary care hospital in Mumbai during 2004-2013: a retrospective cross-sectional study.
    Torane V; Kuyare S; Nataraj G; Mehta P; Dutta S; Sarkar B
    BMJ Open; 2016 Nov; 6(11):e012638. PubMed ID: 27888174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emergence of tetracycline-resistant Vibrio cholerae O1 serotype Inaba, in Kolkata, India.
    Roychowdhury A; Pan A; Dutta D; Mukhopadhyay AK; Ramamurthy T; Nandy RK; Bhattacharya SK; Bhattacharya MK
    Jpn J Infect Dis; 2008 Mar; 61(2):128-9. PubMed ID: 18362401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacteriological profile of cholera in Tamil Nadu (1980-2001).
    Sundaram SP; Revathi J; Sarkar BL; Bhattacharya SK
    Indian J Med Res; 2002 Dec; 116():258-63. PubMed ID: 12807153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomised double blind trial of single dose doxycycline for treating cholera in adults.
    Alam AN; Alam NH; Ahmed T; Sack DA
    BMJ; 1990 Jun; 300(6740):1619-21. PubMed ID: 2196962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization and Genetic Variation of Vibrio cholerae Isolated from Clinical and Environmental Sources in Thailand.
    Siriphap A; Leekitcharoenphon P; Kaas RS; Theethakaew C; Aarestrup FM; Sutheinkul O; Hendriksen RS
    PLoS One; 2017; 12(1):e0169324. PubMed ID: 28103259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changing patient population in Dhaka Hospital and Matlab Hospital of icddr,b.
    Das SK; Rahman A; Chisti MJ; Ahmed S; Malek MA; Salam MA; Bardhan PK; Faruque AS
    Trop Med Int Health; 2014 Feb; 19(2):240-3. PubMed ID: 24252120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diversity of Vibrio cholerae strains isolated in Delhi, India, during 1992-2000.
    Das S; Gupta S
    J Health Popul Nutr; 2005 Mar; 23(1):44-51. PubMed ID: 15884751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trimethoprim and sulfamethoxazole in clinical cholera: comparison with tetracycline.
    Cash RA; Northrup RS; Mizanur Rahman AS
    J Infect Dis; 1973 Nov; 128():Suppl:749-53 p. PubMed ID: 4758056
    [No Abstract]   [Full Text] [Related]  

  • 40. Plasmid profiles and antimicrobial susceptibility patterns of Vibrio cholerae O1 strain isolated during a recent outbreak in Nigeria.
    Olukoya DK; Ogunjimi AA; Abaelu AM
    J Diarrhoeal Dis Res; 1995 Jun; 13(2):118-21. PubMed ID: 7594312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.